Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a research note issued to investors on Wednesday morning. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Down 2.1 %

ENZ opened at $0.52 on Wednesday. Enzo Biochem has a 12 month low of $0.41 and a 12 month high of $1.40. The company has a 50 day moving average of $0.65 and a 200 day moving average of $0.95.

Enzo Biochem (NYSE:ENZ) last posted its quarterly earnings results on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Hedge Funds Weigh In On Enzo Biochem

Large investors have recently modified their holdings of the company. Virtu Financial LLC purchased a new stake in Enzo Biochem in the 4th quarter worth approximately $35,000. Lepercq De Neuflize Asset Management LLC purchased a new stake in shares of Enzo Biochem in the fourth quarter worth $88,000. BBR Partners LLC purchased a new stake in shares of Enzo Biochem in the third quarter worth $112,000. Wittenberg Investment Management Inc. boosted its stake in Enzo Biochem by 60.1% during the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after buying an additional 70,400 shares during the period. Finally, Geode Capital Management LLC grew its position in Enzo Biochem by 3.3% during the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after buying an additional 11,742 shares in the last quarter. 36.90% of the stock is currently owned by institutional investors.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.